Kryogene Cell Freezing Media-CGT
Price range: $340.00 through $410.00
As the specialized cryobiology arm of MileCell, Kryogene delivers scientifically engineered cryopreservation solutions for research and cell therapy.
Developed for next-generation cell therapies, Kryogene Cell Freezing Media – CGT delivers a chemically defined, serum- and protein-free cryopreservation solution that supports high cell viability and functional integrity throughout freezing, storage, and post-thaw recovery.
U.S. FDA Drug Master File (DMF) on file
Product features
- Optimized for cellular therapies: Engineered for CAR-T, NK, MSCs, iPSCs, and other advanced cell therapies.
- Safe & Clinical-grade assurance: Designed for clinical-grade cryopreservation with batch-to-batch consistency. Manufactured under current Good Manufacturing Practice (GMP) standards with USP-compliant raw materials to ensure regulatory alignment.
- Superior cryoprotection: Minimizes ice crystal formation to preserve cell integrity during freeze-thaw cycles.
- High viability retention: Ensures consistent cell function and recovery post-thaw.
- Ready-to-use formulation: Eliminates preparation steps—enhances reproducibility and workflow efficiency.
- Batch-to-batch consistency: Closed, disposable manufacturing process, ensuring no cross-contamination between batches. Rigorous quality control guarantees uniform performance across all production lots.
- Chen, X., Yang, M., Chen, Y., Zhang, Y., Wang, S., Meng, J., Zhu, Z., Li, W., Wei, W., Ping, Y., & Liang, T. (2026). Genetic engineering of systemically injectable oncolytic viruses for pyroptosis-accelerated cancer virotherapy. Nature Cancer, 7(1), 207–223.
- Zhao, K., Yan, Y., Dong, B.-T., Pan, S.-S., & Zhang, X.-Z. (2025). Senescence reprogramming unleashes tumor immune surveillance via coordinated gene modulation. Advanced Materials, e202516597.
- Yu Yan, Kai Zhao, Shan-Shan Pan, Yu-Liang Sun, Zhi-Yong Rao, and Xian-Zheng Zhang, Journal of the American Chemical Society.
- Cui, C., Tang, J., Chen, J., Zhang, B., Li, R., Zhang, Q., Qiu, C., Chen, R., Min, G., Sun, Z., & Weng, H. (2025). Lactobacillus acidophilus extracellular vesicles-coated UiO-66-NH2@siRNA nanoparticles for ulcerative colitis targeted gene therapy and gut microbiota modulation. Journal of Nanobiotechnology, 23(1), 301.



